Real-World data sought on CLL drug acalabrutinib in russia
NCT ID NCT04746950
First seen Jan 04, 2026 · Last updated May 19, 2026 · Updated 23 times
Summary
This study follows about 90 adults with chronic lymphocytic leukemia (CLL) who are taking the drug acalabrutinib as part of their normal care. Researchers will collect information from medical records to see how long patients live without their cancer getting worse and what side effects occur. The goal is to understand how well the drug works in real-life settings across Russia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Ufa, Bashkortostan Republic, 450054, Russia
-
Research Site
Kaliningrad, Kaliningrad Oblast, Russia
-
Research Site
Khabarovsk, Khabarovskiy Kray, 680009, Russia
-
Research Site
Syktyvkar, Komi, Russia
-
Research Site
Krasnoyarsk, Krasnoyarsk Region, 660022, Russia
-
Research Site
Saint Petersburg, Leningradskaya Oblast', 198205, Russia
-
Research Site
Moscow, Moscow Oblast, 125284, Russia
-
Research Site
Moscow, Moscow Oblast, 129110, Russia
-
Research Site
Nizhny Novgorod, Nizhny Novgorod Oblast, Russia
-
Research Site
Novosibirsk, Novosibirsk Oblast, 630091, Russia
-
Research Site
Yakutsk, Sakha Republic, 677008, Russia
-
Research Site
Saratov, Saratov Oblast, 410028, Russia
Conditions
Explore the condition pages connected to this study.